Advancing cervical cancer screening with self-sampling and innovative technologies

Disparities in cervical cancer screening persist in underserved communities, necessitating innovative strategies to improve access and outcomes. Key approaches include integrating self-sampling, which gained acceptance during COVID-19, into healthcare systems to enhance accessibility. Programs should be designed with community input, focusing on high-risk and under-screened groups while addressing socioeconomic barriers. Effective operations, including laboratory readiness, kit management, and reliable postal services, are crucial. Additionally, self-sampling technologies could expand beyond cervical cancer to other HPV-related diseases. Prioritizing high-risk populations and optimizing communication and operations can promote equitable cervical cancer prevention and elimination.

This resource is shared as part of the global #CLINICAL24 conversation